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doi:10.1016/j.ejvs.2008.01.018Abstract Objectives: Renal insufficiency is a risk factor for poor outcome after infrainguinal
bypass in patients with critical limb ischemia (CLI). Estimated glomerular filtration rate (eGFR)
takes age, gender and body size into account and therefore represents actual renal function
more accurately than serum creatinine level alone. The aim of this study was to determine
the impact of different stages of renal insufficiency on outcome and to assess the prognostic
significance of eGFR in patients with CLI.
Material and methods: 603 patients with CLI who underwent infrainguinal bypass between
January 2002 and December 2005 at our institution were included in this retrospective study.
We estimated GFR using the Modification of Diet in Renal Disease (MDRD) Study equation.
Survival, leg salvage and amputation-free survival were calculated using KaplaneMeier
method. Cox regression analysis was performed to calculate hazard ratios for different out-
come variables.
Results: Adjusted hazard ratio (HR) of mortality, limb loss and limb loss and/or death for eGFR
<30 ml/min/1.73 m2 versus serum creatinine >200 mmol/l was 4.0 (95% CI 2.22e7.39) vs 3.5
(95% CI 1.82e6.84), 6.5 (95% CI 2.71e15.59) vs 6.2 (95% CI 2.47e15.56) and 4.0 (95% CI
2.40e6.63) vs 3.6 (95% CI 2.03e6.25), respectively.
Conclusion: Estimated GFR is better predictor of survival, leg salvage and amputation-free
survival than serum creatinine alone. eGFR <30 ml/min/1.73 m2 is independent risk factor
for all three outcome endpoints.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.epartment of Vascular Surgery, Helsinki University Central Hospital, PO Box 340, FI-00029 HUS, Fin-
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Table 1 Staging of renal insufficiency according to Na-
tional Kidney Foundation- Kidney Disease Outcomes Quality
Initiative (NKF- K/DOQI) guidelines and our modification
Stage GFR
(ml/min/
1.73 m2)
Description Our modification
(GFR and description)
1 90 Normal renal
function > 60 no or mild
renal insufficiency2 60e89 Mild renal
insufficiency
3 30e59 Moderate renal
insufficiency
30e60 moderate
renal insufficiency
4 15e29 Severe renal
insufficiency
< 30 severe renal
insufficiency or
renal failure
5 <15 End stage renal
disease (uremia)
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Cardiovascular mortality is higher among patients with end-
stage renal disease (ESRD) compared to normal popula-
tion.1 Dialysis dependent patients have usually heavily
calcified distal arteries and wound healing is poor due to
anemia, malnutrition, impaired immunity and tendency to
infection.2e5 Thus, patients with ESRD and critical limb
ischemia undergoing infrainguinal bypass have poorer
post-operative survival and higher amputation rates.4,6,7
The impact of mild to moderate renal insufficiency on out-
come after arterial reconstructions is less well known. Dia-
betes mellitus and hypertension are most common
underlying causes of renal insufficiency and may further
worsen the outcome.8e10 However, renal insufficiency per
se seems to be independent risk factor for poor progno-
sis.11,12 Chronic inflammatory activity and endothelial dys-
function are found in patients with albuminuria and
elevated serum creatinine levels independently of other
cardiovascular risk factors and this seems to be associated
to progression of atherosclerosis.8,13,14
Measurement of serum creatinine is most commonly
used method to assess renal function, but it is an inaccurate
estimate of actual renal function, especially in early renal
insufficiency.15 Direct measurement of glomerular filtration
rate is the gold standard, but neither inulin clearance nor
isotopic methods are practical in clinical use. Glomerular
filtration rate can, however, be estimated with serum cre-
atinine based equations; either Modification of Diet in renal
Disease (MDRD)16 or Cockcroft-Gault (CG)17 formula. These
formulas take age, gender, and body size into consideration
and are therefore much more accurate in estimating renal
function than serum creatinine alone. For example,
glomerular filtration rate can in some patients decline to
half the normal level before creatinine level reaches the
upper limit of normal.18 There is evidence, that reduced
estimated glomerular filtration rate (eGFR) is associated
with increased postoperative mortality both after cardiac19
and other vascular20,21 procedures.
The aim of this study was to assess the usefulness of
eGFR as a predictor of survival, leg salvage and amputation-
free survival after infrainguinal revascularization in CLI
patients and, specifically, find out the impact of moderate
renal insufficiency on the outcome.
Material and Methods
We retrospectively reviewed our institution’s vascular
registry (Husvasc). Consecutive 603 patients who under-
went infrainguinal bypass for chronic critical limb ischemia
(Fontaine class III or IV) between January 1st 2002 and
December 31st 2005 at our institution were included in the
study. Registry includes patient demographics, comorbid
conditions, indications for surgery, specific operative de-
tails, complications and outcome at discharge. Follow-up
data includes graft patency and dates of any graft revision
or graft occlusion and also dates of major amputation or
death. Dates of death were retrieved from population
registry center. Follow-up visits according to our surveil-
lance programme were at 1, 6, 12 and 24 months. Registry
data of all patients included in study were cross-checkedagainst patient records and any missing data in the registry
was retrieved from the patient’s records.
Primary end point was major amputation or death. Only
amputations above the ankle were considered as major
amputations. Serum creatinine (Scr) was measured one day
before surgery. Serum creatinine levels were measured using
IDMS (isotope dilution-mass spectrometry) traceable enzy-
matic assay (Roche Diagnostics, Basel, Switzerland), which is
one of the most accurate methods available at present.22 Glo-
merular filtration rate was estimated using the 4-variable Mod-
ification of Diet in Renal Disease (MDRD) Study equation for
creatinine results traceable to an IDMS method : eGFR (mL/
min/1.73 m2)Z 175 (Scr/88.4)1.154 (Age)0.203 (0.742
if female) (1.210 if African American) (SI units).22e24 Chronic
kidney disease (CKD) is divided into five stages according to
The National Kidney Foundation - Kidney Disease Outcomes
Quality Initiative (NKF-K/DOQI) guidelines25 (Table 1). We
summed up stages 1 and 2 as well as stages 4 and 5 to establish
three categories : eGFR>60 ml/min/1.73 m2 (no or mild renal
insufficiency), eGFR 30e60 ml/min/1.73 m2 (moderate renal
insufficiency) and eGFR <30 ml/min/1.73 m2 (severe renal in-
sufficiency or renal failure) (Table 1). Comparisons between
groups were made using Kruskal-Wallis test for continuous var-
iables and Chi-squared test for categorial variables. Median
and interquartile range was also calculated for continuous var-
iables. Serum creatinine was analysed as categorical variable
as well by establishing three categories for comparison with
GFR, i.e. S-creatinine <120 mmol/L, S-creatinine 120e
200 mmol/L, and S-creatinine >200 mmol/L. The lower cut-of
value was selected, because it is generally considered the up-
per limit of normal creatinine value. The upper cut-of value of
200 mmol/L was selected, because values above it represent
severe renal insufficiency. Values between these cut-off points
represent therefore moderate renal insufficiency.
The median age of study population was 73 years
(interquartile range 65e80). The median follow-up time
was 5 months (interquartile range 0e46 months). Baseline
characteristics and co-morbidities of study population are
presented in details in Table 2. Indication was critical limb
ischemia in all patients, 40% had rest pain and 60% had ulcer
or gangrene. The proportions of femoro-popliteal, crural
and pedal bypasses were 181(30%), 261(43%) and 81(13%),
Table 2 Baseline patient characteristics by renal function
Characteristic All (nZ 603) GFR >60 (nZ 366) GFR 30e60 (nZ 176) GFR <30 (nZ 61) p-value
Age, median (IQ range) 73 (65e80) 72 (64e78) 78 (71e83) 68 (59e78) <0.0001a
eGFR, median (IQ range) 67 (46e89) 84 (69e103) 46 (38e52) 18 (9e25) <0.0001a
SCr, median (IQ range) 86 (67e116) 71 (59e83) 116 (97e133) 291 (194e506) <0.0001a
Male gender 330 (55%) 219 (60%) 73 (42%) 38 (62%) <0.0001
CAD 359 (63%) 198 (57%) 120 (72%) 41 (71%) 0.002
Diabetes 276 (47%) 154 (43%) 83 (48%) 39 (65%) 0.006
Hyperlipidemia 229 (48%) 139 (47%) 64 (47%) 26 (62%) 0.185
Hypertension 397 (68%) 218 (62%) 133 (78%) 46 (78%) <0.0001
Current smoking 173 (30%) 125 (36%) 37 (22%) 11 (19% 0.003
COPD 111 (19%) 63 (18%) 38 (23%) 10 (17%) 0.392
History of TIA/stroke 116 (20%) 69 (20%) 35 (21%) 12 (21%) 0.908
Fontaine class IV 359 (60%) 204 (56%) 116 (66%) 39 (64%) 0.491
IQZ interquartile.
eGFRZ estimated glomerular filtration rate.
SCrZ serum creatinine.
CADZ coronary artery disease.
a Kruskal-Wallis test is used for continuous variables and chi-squared test for dichotomous variables.
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autologous vein as graft material.
Kaplan-Meier method was used to calculate cumulative
survival, leg salvage and amputation-free survival. Crude
hazard ratios (HR) of mortality, limb loss and amputation
and/or death were calculated for both eGFR and creatinine
using Cox regression analysis. 95% confidence intervals (CIs)
for HRs were also calculated. Adjusted hazard ratios with
95 % CIs were also calculated for both eGFR and creatinine.
All confounding variables in Table 2 and also location of
bypass operation or use of autologous versus other graft
material were taken in to this adjusted regression model.
HRs were calculated using eGFR and creatinine as continu-
ous and as categorial variables. All statistical analyses were
performed using SPSS for Windows, version 13.0 (SPSS inc.,
Chicago, Ill., USA). P-value of 0.05 was considered as
statistically significant.
Results
According to estimated eGFR, 60.7% of patients (nZ 366)
had normal or mildly impaired kidney function (eGFR
>60 ml/min/1.73 m2), 29.2% (nZ 176) had moderate renal
insufficiency (eGFR 30e60 ml/min/1.73 m2) and 10.1 % of
patients (nZ 61) had severe renal insufficiency or kidney
failure (eGFR <30 ml/min/1.73 m2). However, according
to serum creatinine level 77.4% (nZ 467) had normal renal
function (creatinine <120 mmol/L) and only 15.1% (nZ 91)
and 7.5% (nZ 45) had moderate (creatinine 120e200 mmol/
L) and severe (creatinine >200 mmol/L) renal insufficiency,
respectively. The incidence of coronary artery disease,
hypertension, and diabetes were higher in groups of moder-
ate and severe renal insufficiency compared to those who
had normal or just mildly impaired kidney function
according to eGFR. There was not statistically significant
difference in incidence of hyperlipidemia, COPD, or cere-
brovascular disease between groups. eGFR groups were
also similar according to Fontaine classification (Table 2).
Neither was there statistical difference between groups
according to the location of original infra-inguinal bypassnor according to use of autologous versus other graft
material.
Survival, leg salvage and amputation-free survival at one
and two years are presented as Kaplan-Meier curves in Figs.
1e3. Adjusted hazard ratio (HR) of mortality, limb loss and
limb loss and/or death for eGFR <30 ml/min/1.73 m2 versus
serum creatinine>200 mmol/l was 4.0 (95% CI 2.22e7.39) vs
3.5 (95% CI 1.82e6.84), 6.5 (95% CI 2.71e15.59) vs 6.2 (95%
CI 2.47e15.56) and 4.0 (95% CI 2.40e6.63) vs 3.6 (95% CI
2.03e6.25), respectively. Both crude and adjusted hazard
ratios of mortality, limb loss and amputation and/or death
for both eGFR and serum creatinine are presented in Tables
3 and 4.
Discussion
Infrainguinal revascularizations, be those bypass or endo-
vascular, are useless unless limb and life are preserved.
Renal insufficiency among other concurrent diseases plays
a paramount role in this context. Serum creatinine value
has been criticized to be inaccurate to identify mild renal
insufficiency.15,18 Indeed, in the present study, the number
of patients with mild to moderate renal insufficiency was
larger when eGFR instead of serum creatinine was used to
assess renal function. Low estimated GFR turned out to
be the most powerful independent predictor of mid-term
death and limb loss. In our series the incidence of diabetes,
hypertension and coronary artery disease increased with
reduced eGFR, and this is probably one confounding factor.
However, diabetes and hypertension are most common un-
derlying conditions of chronic renal insufficiency and CKD
patients have higher incidence of advanced atherosclerosis
and coronary artery disease.8,9 The average follow-up time
in our series was only 8 months (median 5 months, range 0e
46 months) which was mainly due to very high end point
rate: there were 43 deaths per 100 person years and 16 am-
putations per 100 person years. However, there was also
missing follow-up data. The number of patients attending
post-operative follow-up visits at 1, 6 and 12 months was
481 (80%), 380 (63%) and 299 (50%), respectively. Patients
Figure 1 a. One year cumulative survival for eGFR >60
(green line), eGFR 30e60 (black line) and eGFR <30 (red
line) is 78.6%, 57.0% and 45.7% respectively. b. One year cumu-
lative survival for Scr >120 (green line), Scr 120e200 (black
line) and >200 (red line) is 74.5%, 49.8% and 47.9%, respec-
tively. Numbers above time axis represent patients at risk.
Figure 2 a. One year cumulative leg salvage for eGFR >60
(green line), eGFR 30e60 (black line) and eGFR <30 (red line)
is 86.5%, 80.5% and 54.7%, respectively. b. One year cumulative
leg salvage for Scr >120 (green line), Scr 120e200 (black line)
and >200 (red line) is 86.4%, 71.0% and 52.1%, respectively.
Numbers above time axis represent patients at risk.
80 E. Arvela et al.with critical limb ischemia are old and have usually several
comorbid conditions, which is probably the main reason we
lost patients from our surveillance program.
In recent years only a few authors have published about
the association between estimated GFR and survival after
infrainguinal bypass. O’Hare et al.26 found renal insuffi-
ciency to be a strong independent predictor of mortality
in CLI patients and that mortality risk was highest among
patients with a GFR <30 ml/min/1.73 m2. Similarly, GFR
<30 ml/min/1.73 m2 was a strongly and independently as-
sociated with increased risk of death and limb loss in our
study. Maithel et al.21 recently showed, that independent
of dialysis status, estimated GFR but not serum creatinine
predicted also long term survival after lower limb revascu-
larization. In their series, reduced eGFR was associated to
higher mortality up to three years after bypass.
The association of renal insufficiency and increased
amputation rate is more controversial. According to O’Hareet al.27 dialysis dependent patients, but not patients with
milder degrees of renal insufficiency, had high amputation
rates. In the same series they found, that 46% of patients
receiving dialysis were alive with salvaged leg at 1 year.
In our series, eGFR <30 ml /min/1.73 m2 was independent
predictor of limb loss and death in regression model and
only 38.7% of patients with severe renal insufficiency
were alive with leg at one year. Also patients with moder-
ate renal insufficiency had higher hazard ratios of limb
loss and death and significantly poorer one year amputa-
tion- free survival than patients with no or mild renal
insufficiency.
Long term amputation-free survival in patients with
severe renal insufficiency is poor. Owens et al.28 published
49% 3% 5-year amputation-free survival for eGFR >30 ml/
min/1.73 m2 but only 8% 4% in patients with eGFR
<30 ml/min/1.73 m2. Coronary artery disease and poor nu-
tritional status seem to further worsen the outcome of
Figure 3 a. One year cumulative amputation-free survival
for eGFR >60 (green line), eGFR 30e60 (black line) and eGFR
<30 (red line) is 73.2%, 54.7% and 38.7%, respectively. b. One
year cumulative amputation-free survival for Scr >120 (green
line), Scr 120e200 (black line) and >200 (red line) is 69.8%,
46.2% and 42.2%, respectively. Numbers above time axis repre-
sent patients at risk.
Table 3 Crude hazard ratios for different outcome
variables
Variable HR 95% CI p-value
Survival
eGFR(continuous) 0.99 0.98e0.99 <0.0001
eGFR (categoriala)
eGFR 30e60 1.80 1.27e2.54 0.001
eGFR <30 2.63 1.69e4.09 0.001
S-creatinine (continuous) 1.00 1.00e1.00 <0.0001
S-creatinine (categoriala)
Scr 120e200 1.90 1.30e2.78 0.001
Scr >200 2.18 1.38e3.45 0.001
Leg salvage
eGFR (continuous) 0.99 0.98e0.99 0.024
eGFR (categoriala)
eGFR 30e60 1.68 0.95e2.98 0.073
eGFR <30 4.00 2.01e7.97 <0.0001
S-creatinine (continuous) 1.00 1.00e1.01 <0.0001
S-creatinine (categoriala)
Scr 120e200 2.55 1.39e4.69 0.003
Scr >200 3.62 1.74e7.56 0.001
Amputation-free survival
eGFR (continuous) 0.99 0.98e0.99 <0.0001
eGFR (categoriala)
eGFR 30e60 1.70 1.24e2.34 0.001
eGFR <30 2.83 1.91e4.20 <0.0001
S-creatinine (continuous) 1.00 1.00e1.00 <0.0001
S-creatinine (categoriala)
Scr 120e200 1.89 1.33e2.67 <0.0001
Scr >200 2.31 1.52e3.52 <0.0001
a For the categorial results the HRs are relative to the baseline
renal groups of eGFR >60 or SCr< 120.
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institution29 revealed as poor as 12% one year amputation-
free survival after infrainguinal revascularization in dialysis
depended patients with critical limb ischemia and coronary
artery disease. In same series, low serum albumin concen-
tration was also risk factor for poor outcome.
Several studies have showed, that eGFR reflects actual
renal function better than serum creatinine alone, but
there has also been lot of criticism concerning the use of
GFR estimation formulas. A major concern is the accuracy
of creatinine assay itself. Due to that it is now recom-
mended that all creatinine methods should become trace-
able to a reference method based on isotope dilution-mass
spectrometry (IDMS). Recalibration of creatinine methods
to be traceable to IDMS requires the use of revised MDRD
equation with a 6% change in calculation factor from a value
of 186 to 175.22e24 Both MDRD and CockcrofteGault (CG)formulas are developed and validated in populations with
CKD. Therefore they are not as accurate in patients without
known kidney disease and estimated GFR seems to underes-
timate actual renal function in patients with normal
kidneys.30,31 There is also evidence, that these estimating
formulas are useful in patients with good nutrition, but
they are not as accurate in elderly patients with poor nutri-
tional status.32 CG formula includes weight, and it tends to
overestimate the GFR in obese patients. MDRD formula on
the other hand overestimates renal function in underweight
patients.33 The advantage of MDRD formula is that patient’s
weight is not required, which was also the main reason for
its use instead of CG formula in this study. There is also
some evidence, that MDRD formula may perform better
than CG in CKD patients with respect to accuracy.33,34 De-
spite of their limitations, serum creatinine based estimat-
ing formulas, such as MDRD, remain the best alternative
to assess renal function in every day clinical practise.
Conclusion
Renal insufficiency, not only renal failure, but also moder-
ate impairment of renal function, seems to be a significant
risk factor for both limb loss and death after infrainguinal
bypass in patients with critical limb ischemia. Low eGFR
(<30 ml/min/1.73 m2) is a marker of even higher hazard.
Table 4 Adjusted hazard ratios for different outcome
variables
Variable HR 95% CI p-value
eGFR(continuous) 0.98 0.98e0.99 <0.0001
eGFR 30e60 1.87 1.22e2.87 0.004
eGFR <30 4.05 2.22e7.39 <0.0001
S-creatinine (continuous) 1.00 1.00e1.01 <0.0001
S-creatinine (categoriala)
Scr 120e200 2.18 1.33e3.59 0.002
Scr >200 3.53 1.82e6.84 <0.0001
Leg salvage
eGFR (continuous) 1.00 1.00e1.01 <0.0001
eGFR 30e60 1.61 0.78e3.35 0.199
eGFR <30 6.51 2.71e15.59 <0.0001
S-creatinine (continuous) 0.99 0.98e1.00 0.106
S-creatinine (categoriala)
Scr 120e200 2.27 1.01e5.13 0.048
Scr >200 6.20 2.47e15.56 <0.0001
Amputation-free survival
eGFR (continuous) 0.99 0.98e1.00 <0.0001
eGFR (categoriala)
eGFR 30e60 1.66 1.12e2.47 0.012
eGFR <30 3.99 2.40e6.63 <0.0001
S-creatinine (continuous) 1.00 1.00e1.01 <0.0001
S-creatinine (categoriala)
Scr 120e200 1.82 1.16e2.85 0.010
Scr >200 3.56 2.03e6.25 <0.0001
Both eGFR and Scr are adjusted for age, gender, coronary artery
disease, diabetes, hyperlipidemia, hypertension, smoking,
COPD, history of TIA or stroke, fontaine class, location of orig-
inal infra-inguinal bypass operation and use of autologous ver-
sus other graft type.
a For the categorial results the HRs are relative to the baseline
renal groups of eGFR >60 or SCr <120.
82 E. Arvela et al.Regardless of its limitations, estimated GFR is more
accurate predictor of survival and leg salvage after infrain-
guinal bypass in CLI patients than serum creatinine alone.
Therefore we conclude, that GFR estimation should be
used instead of creatinine level alone in risk evaluation of
patients undergoing infrainguinal revascularization for
critical limb ischemia.
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